[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359643-105":59,"doc-detail-359643-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prostate-stem-cell-antigen-targeted-dna-aptamer-probe-with-ultrahigh-tumor-contrast-for-precision-fluorescence-guided-surgery-of-prostate-cancer","Prostate Stem Cell Antigen-Targeted DNA Aptamer Probe with Ultrahigh Tumor Contrast for Precision Fluorescence-Guided Surgery of Prostate Cancer","","Fluorescence-guided surgery (FGS) aims to improve complete tumor resection in prostate cancer, but existing probes are constrained by insufficient tumor-to-background ratio (TBR). The study develops GGA-sNIR, a near-infrared fluorescent probe formed by conjugating a PSCA-specific high-affinity DNA aptamer to a monocarboxy indocyanine green (ICG) derivative. The conjugate adopts a stable 3D structure that enhances nuclease resistance and in vivo stability, enabling nanomolar binding (Kd=54.91 nM) and PSCA-positive cell internalization. In subcutaneous models, GGA-sNIR reaches peak TBR 26 and retains tumors beyond 48 h; in orthotopic PCa models it visualizes tumor margins during laparoscopic surgery with real-time high contrast, and ex vivo human lymph node testing confirms selective detection of PSCA-positive metastases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prostate-stem-cell-antigen-targeted-dna-aptamer-probe-with-ultrahigh-tumor-contrast-for-precision-fluorescence-guided-surgery-of-prostate-cancer/359643/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prostate-stem-cell-antigen-targeted-dna-aptamer-probe-with-ultrahigh-tumor-contrast-for-precision-fluorescence-guided-surgery-of-prostate-cancer/359643.png","ImageObject",300,407,{"name":92,"@type":93},"Maya Linwood","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What limitation of current probes restricts fluorescence-guided surgery in prostate cancer?","Question",{"text":112,"@type":113},"Clinical use is limited by an insufficient tumor-to-background ratio (TBR) of available probes, which reduces contrast during surgery.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is GGA-sNIR designed, and why does it improve stability?",{"text":117,"@type":113},"GGA-sNIR is engineered by conjugating a high-affinity DNA aptamer targeting prostate stem cell antigen (PSCA) with a monocarboxy indocyanine green (ICG) derivative, adopting a stable 3D structure that protects against nuclease degradation and improves in vivo stability.",{"name":119,"@type":110,"acceptedAnswer":120},"What performance did GGA-sNIR achieve in tumor models and surgery?",{"text":121,"@type":113},"In subcutaneous models it achieved a peak TBR of 26 with prolonged tumor retention over 48 hours; in an orthotopic model it enabled real-time, high-contrast visualization of tumor margins during laparoscopic surgery and supported precise, complete resection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359643,1790167439,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","This article is licensed under CC-BY-NC-ND 4.0  \n[pubs.acs.org/bc](pubs.acs.org/bc)  Article   \nProstate Stem Cell Antigen-Targeted DNA Aptamer Probe with Ultrahigh Tumor Contrast for Precision Fluorescence-Guided Surgery of Prostate Cancer  \nFen Hu,\\# Yong Liu,\\# Mao-Yin Li, Yu-Bin Cui, Yi-Qian Wan, Xin Gao,* Man-Na Huang,* and Yu Wang*  \n Cite This: Bioconjugate Chem. 2026, 37, 766−778  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Fluorescence-guided surgery (FGS) offers a potential strategy to improve complete tumor resection in prostate cancer (PCa); however, clinical application has been limited by an insufficient tumor-to-background ratio (TBR) of available probes. Here, we report the development of GGA-sNIR, a near-infrared (NIR) fluorescent probe engineered by conjugating a high-affinity DNA aptamer specific for a prostate stem cell antigen (PSCA) with a monocarboxy indocyanine green (ICG) derivative. The conjugate adopts a stable three-dimensional structure that not only enables precise target recognition but also protects against nuclease degradation, markedly enhancing its in vivo stability. GGA-sNIR exhibits nanomolar binding affinity (Kd = 54.91 nM) and is  \nspecifically internalized by PSCA-positive cells. In subcutaneous tumor models, the probe achieved a peak TBR of 26 and showed prolonged tumor retention exceeding 48 h. Crucially, in an orthotopic PCa model, GGA-sNIR allowed real-time, high-contrast visualization of tumor margins during laparoscopic surgery, facilitating precise and complete resection. Further validation using ex vivo human lymph node specimens confirmed its ability to selectively detect PSCA-positive metastases. With its ultrahigh contrast, demonstrated efficacy in intraoperative guidance, and strong translational potential, GGA-sNIR represents a promising molecular tool for advancing precision surgery in prostate cancer.  \n■ INTRODUCTION  \nProstate cancer (PCa) represents the second most prevalent malignancy and fifth leading cause of cancer-related mortality among men worldwide, underscoring its significant global health burden1 Radical prostatectomy (RP) combined with extended pelvic lymph node dissection (ePLND) remains the standard curative treatment for localized and locally advanced disease. However, contemporary surgical management faces two fundamental challenges that significantly impact oncological outcomes and patient prognosis. The primary challenge involves achieving complete tumor eradication while preserving negative surgical margins􀀁a critical determinant of long-term survival. The anatomical complexity of the prostate, particularly the intimate relationship between malignant tissue and neurovascular bundles, presents substantial technical difficulties for surgeons attempting precise tumor resection while preserving functional outcomes. The second challenge centers on the detection and removal of micrometastatic disease, particularly in lymph nodes located adjacent to critical anatomical structures including major vessels, nerve plexuses, bladder neck, and rectum. These anatomical constraints considerably complicate surgical decision-making and increase the risk of incomplete resection.  \nThe clinical significance of these challenges is reflected in compelling epidemiological data. Unlike developed nations where earlier detection is common, over 68% of Chinese patients present with locally advanced or metastatic disease at initial diagnosis.2 Comprehensive analyses reveal alarming rates of positive surgical margins following RP: 19.58% in pT2 disease and 45.95% in pT3 tumors.3 Furthermore, lymphovascular invasion occurs in 4.9% of pT2, 67.5% of pT3, and 75% of pT4 cases.4 Perhaps most concerning, Schiavina and colleagues demonstrated that 13% of lymph nodes initially classified as pathologically negative harbored occult micrometastases when subje","cbCaibLyN9o1Oh5Q","https://ap.wps.com/l/cbCaibLyN9o1Oh5Q","pdf",13232972,13,"English","# Abstract\n# Introduction","[{\"question\":\"What limitation of current probes restricts fluorescence-guided surgery in prostate cancer?\",\"answer\":\"Clinical use is limited by an insufficient tumor-to-background ratio (TBR) of available probes, which reduces contrast during surgery.\"},{\"question\":\"How is GGA-sNIR designed, and why does it improve stability?\",\"answer\":\"GGA-sNIR is engineered by conjugating a high-affinity DNA aptamer targeting prostate stem cell antigen (PSCA) with a monocarboxy indocyanine green (ICG) derivative, adopting a stable 3D structure that protects against nuclease degradation and improves in vivo stability.\"},{\"question\":\"What performance did GGA-sNIR achieve in tumor models and surgery?\",\"answer\":\"In subcutaneous models it achieved a peak TBR of 26 with prolonged tumor retention over 48 hours; in an orthotopic model it enabled real-time, high-contrast visualization of tumor margins during laparoscopic surgery and supported precise, complete resection.\"}]","Prostate Stem Cell Antigen-Targeted DNA Aptamer Probe with Ultrahigh Tumor Contrast for Precision Fluorescence-Guided Surgery of Prostate Cancer | PDF",1790137363,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69339a2e5247a2c4217954870b72874f.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d42faa642e48e5230e5d6973063ee14e.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e29ec8194970f2476758fa36e112355.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bd7f1a6956ca2a6c1073ccfdb7c4f18.webp",980,1292]